Share
Herpes and Alzheimer's
Matthew Horne
(Author)
·
Punishment Press
· Paperback
Herpes and Alzheimer's - Horne, Matthew
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Tuesday, June 11 and
Thursday, June 27.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Herpes and Alzheimer's"
Multiple infectious pathogens have been associated with Alzheimer's. Medication may reduce the risk of dementia by suppressing several types of herpes viruses. Acyclovir 200 mg per day, and/or Amenamevir 100 mg per day may be effective.It is unknown if pathogens slowly eat away at the brain tissue over many years, or very quickly as the immune system senesces in old age. Regardless, cognitive impairment may only appear when very little brain tissue is left in certain areas. As with other body systems, problems may not appear until 80 to 95% of functional tissue is gone, by then it is "too late." To avert brain deterioration reaching "end-stage" disease, taking daily medication beginning at age 60 to 65 is reasonable. Persons at high risk may consider starting earlier.Brain damage and neuron loss is permanent, so the only way to keep the brain working is to prevent initial break down.Research studies support antiviral medication to prevent dementia. Further validation is forthcoming as several clinical trials are in progress to determine effectiveness of this approach.This book is a new edition of Dr. Horne's Prevention and Treatment for Alzheimer's Dementia Based on the Infection Model; a Discussion, with a new chapter on helicase primase inhibitor drugs.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
